查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587400

病理實驗室市場規模、佔有率、趨勢分析報告：按類型、按實驗室服務、按最終用途、按地區、細分市場預測，2025-2030 年

Pathology Laboratories Market Size, Share & Trends Analysis Report By Type, By Testing Services, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

病理實驗室市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球病理實驗室市場規模將達到6,122.2億美元，2025年至2030年複合年成長率為8.1%。

推動該行業的關鍵因素包括預期壽命的延長、開發中國家醫療保健基礎設施的改善、報銷的增加以及定期體檢需求的增加。

此外，技術進步正在改變診斷的動態。創新技術使即時檢測 (POCT) 設備變得便攜，並改進了採樣技術，使診斷服務更加便捷和高效。預計多項進步將透過品質、速度、效率和擴充性來指導患者照護，從而改變整個行業。醫療保健系統逐漸強調病理和診斷實驗室的重要性，它們不僅可以更快、更準確地監測患者，還可以協助醫生做出推論和診斷，成為更大的臨床決策引擎。

COVID-19 大流行導致對病理學和診斷實驗室的需求增加，因為在大流行期間需要對 COVID-19 進行檢測。 COVID-19 感染的激增導致資金和測試的增加，從而促進了整體市場的成長。例如，2020 年 9 月，美國國立衛生研究院 (NIH) 宣布，Maxim Biomedical Inc. 將擴大對一套新的 COVID-19 檢測技術的製造支持，作為舉措的一部分，宣布投入129.3美元。

病理實驗室市場報告亮點

  • 按類型分類，醫院診斷實驗室將在 2024 年佔據市場主導地位。這是因為醫院提供的先進測試已成為複雜診斷的最佳解決方案。
  • 根據最終用途，醫師轉診將在 2024 年佔據市場主導地位。由於監控個人健康和保健的自我認知增強，預計步入式客戶和企業客戶將出現良好的成長。
  • 由於美國最流行的疾病，預計美國對心血管健康診斷的需求將會很高。
  • 預計歐洲在預測期內將出現較大的複合年成長率。根據世界癌症研究基金會的數據，丹麥是全球癌症盛行率最高的國家。
  • 在這個市場上，主要企業最近開展了多個聯合研究項目，旨在提高服務付加並擴大研究範圍。例如，2022年7月，Unilab宣布與Subtle Medical建立合作關係，成為第一家採用該公司基於人工智慧的MRI技術進行高品質、快速MRI的診斷公司。該解決方案將首先在瑞典推出。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章病理實驗室市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 病理實驗室市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章病理實驗室市場：類型估計和趨勢分析

  • 細分儀表板
  • 病理實驗室市場：類型變異分析
  • 病理實驗室市場：按類型分類的展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院
  • 獨立實驗室
  • 診斷專業

第5章病理實驗室市場：實驗室服務的估計和趨勢分析

  • 細分儀表板
  • 病理實驗室市場：實驗室服務波動分析
  • 病理實驗室市場：實驗室服務展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 一般生理和實驗室測試
  • 影像檢查和放射學檢查
  • 困難的考驗
  • COVID-19 測試

第6章病理實驗室市場：最終用途估計和趨勢分析

  • 細分儀表板
  • 病理實驗室市場：最終用途變異分析
  • 病理實驗室市場：最終用途展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫生介紹
  • 步入式
  • 公司

第7章病理實驗室市場：區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 主要市場參與企業的最新趨勢和影響分析
  • 2024 年企業市場佔有率分析
  • 主要企業簡介
    • Quest Diagnostics Incorporated
    • Eurofins Scientific
    • Laboratory Corporation of America Holdings
    • Exact Sciences Laboratories LLC
    • Spectra Laboratories
    • SYNLAB International GmbH
    • Sonic Healthcare Limited
    • DR Lal Path Labs.
    • Metropolis Healthcare
    • Kingmed Diagnostics
Product Code: GVR-4-68039-987-6

Pathology Laboratories Market Growth & Trends:

The global pathology laboratories market size is estimated to reach USD 612.22 billion by 2030, registering a CAGR of 8.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The major factors driving the industry include increasing life expectancy, the development of healthcare infrastructure in developing nations, favoring reimbursement, and rising demand for routine medical check-ups.

In addition, the advancement of technology is altering the dynamics of diagnosis. Innovative technologies have made Point of Care Testing(POCT) devices portable and improved sampling techniques, making diagnostic services more accessible and efficient. Several advancements are expected to transform the industry by steering patient care through quality, speed, efficiency, and scalability. The healthcare system is progressively emphasizing the importance of pathological & diagnostic labs in becoming a greater clinical decision-making engine, assisting physicians in making inferences and diagnosing as well as monitoring patients more quickly and accurately.

The COVID-19 pandemic has resulted in higher demand for pathology/diagnostic labs as the testing for COVID-19 was necessary during the pandemic. The rapid rise of COVID-19 infections has resulted in increased funding and testing, which has boosted the overall market growth. For instance, the (NIH) National Institutes of Health in the United States announced in September 2020 that it would grant USD 129.3 million in funding to nine organizations including, Maxim Biomedical Inc., MatMaCorp, MicroGEM International, & others, for scaling-up manufacturing assistance to a new set of COVID-19 testing technologies as component of its initiative to boost diagnostics in the region.

Pathology Laboratories Market Report Highlights:

  • Based on type, hospital-based diagnostic labs dominated the market during the year 2024. This can be attributed to the advanced tests available at hospitals, making them the only best solution for complex diagnosis
  • Based on the end use, physician referrals dominated the market in 2024. Walk-in and corporate clients are expected to witness lucrative growth due to increased self-awareness for monitoring health and wellness among individuals
  • U.S. is expected to have a high demand for the diagnosis of cardiovascular health as a result of the most prominent disease in the U.S.
  • Europe is expected to have a significant CAGR during the forecast period. Denmark has the highest prevalence of cancer globally in terms of cancer prevalence as per the World Cancer Research Fund International
  • The market is witnessing multiple collaborations in recent times with the key players aiming at adding value to their services & expanding their research. For Instance, in July 2022, Unilabs announced a partnership with Subtle Medical, to be the first diagnostic company to adopt their AI-based MRI technology for high-quality & quick MRI. The solution will be first launched in Sweden.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Testing Services
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Pathology Laboratories Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Improving healthcare infrastructure in developing countries
      • 3.2.1.2. Increasing demand for regular general health check-ups
      • 3.2.1.3. Gowning reimbursement for diagnostics services
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Affordability for high-end molecular diagnostics
      • 3.2.2.2. Shortage of skilled workforce
  • 3.3. Pathology Laboratories Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Pathology Laboratories Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pathology Laboratories Market: Type Movement Analysis
  • 4.3. Pathology Laboratories Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Hospital Based
    • 4.5.1. Hospital Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Standalone Labs
    • 4.6.1. Standalone Labs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Diagnostic Chains
    • 4.7.1. Diagnostic Chains Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pathology Laboratories Market: Testing Services Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pathology Laboratories Market: Testing Services Movement Analysis
  • 5.3. Pathology Laboratories Market by Testing Services Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. General Physiological & Clinical Tests
    • 5.5.1. General Physiological & Clinical Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Imaging & Radiology Tests
    • 5.6.1. Imaging & Radiology Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Esoteric Tests
    • 5.7.1. Esoteric Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. COVID-19 Tests
    • 5.8.1. COVID-19 Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pathology Laboratories Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pathology Laboratories Market: End Use Movement Analysis
  • 6.3. Pathology Laboratories Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Physician Referrals
    • 6.5.1. Physician Referrals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Walk-Ins
    • 6.6.1. Walk-Ins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Corporate
    • 6.7.1. Corporate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pathology Laboratories Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Recent Developments & Impact Analysis by Key Market Participants
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Key Company Profiles
    • 8.4.1. Quest Diagnostics Incorporated
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Eurofins Scientific
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Laboratory Corporation of America Holdings
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Exact Sciences Laboratories LLC
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Spectra Laboratories
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. SYNLAB International GmbH
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Sonic Healthcare Limited
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. DR Lal Path Labs.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Metropolis Healthcare
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Kingmed Diagnostics
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 4. Global Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 5. Global Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 6. North America Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 7. North America Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 8. North America Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 9. U.S. Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 10. U.S. Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 11. U.S. Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 12. Canada Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 13. Canada Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 14. Canada Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 15. Mexico Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 16. Mexico Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 17. Mexico Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 18. Europe Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 19. Europe Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 20. Europe Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 21. UK Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 22. UK Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 23. UK Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 24. Germany Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 25. Germany Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 26. Germany Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 27. France Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 28. France Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 29. France Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 30. Italy Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 31. Italy Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 32. Italy Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 33. Spain Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 34. Spain Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 35. Spain Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 36. Denmark Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 37. Denmark Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 38. Denmark Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 39. Sweden Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 40. Sweden Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 41. Sweden Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Norway Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 43. Norway Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 44. Norway Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 45. Asia Pacific Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 46. Asia Pacific Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 48. Japan Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 49. Japan Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 50. Japan Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 51. China Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 52. China Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 53. China Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 54. India Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 55. India Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 56. India Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 57. Australia Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 58. Australia Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 59. Australia Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 60. South Korea Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 61. South Korea Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 62. South Korea Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 63. Thailand Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 64. Thailand Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 65. Thailand Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 66. Latin America Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 67. Latin America Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 68. Latin America Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 69. Brazil Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 70. Brazil Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 71. Brazil Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 72. Argentina Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 73. Argentina Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 74. Argentina Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 75. Middle East & Africa Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 76. Middle East & Africa Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 77. Middle East & Africa Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 78. South Africa Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 79. South Africa Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 80. South Africa Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 81. Saudi Arabia Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 82. Saudi Arabia Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 83. Saudi Arabia Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 84. UAE Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 85. UAE Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 86. UAE Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)
  • Table 87. Kuwait Pathology Laboratories market, by Type, 2018 - 2030 (USD Million)
  • Table 88. Kuwait Pathology Laboratories market, by Testing Services, 2018 - 2030 (USD Million)
  • Table 89. Kuwait Pathology Laboratories market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Pathology Laboratories market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Pathology Laboratories market, Type outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 12 Pathology Laboratories market, Testing Services outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 13 Pathology Laboratories market, End-Use outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 14 Hospital Based market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Imaging Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Respiratory Measurement Devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Other Hospital Based market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Standalone Labs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Diagnostic Chains market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 General Physiological & Clinical Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Imaging & Radiology Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Esoteric Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 COVID-19 Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Physician Referrals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Walk-ins market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Corporate market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 North America Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 US Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Germany Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 France Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Spain Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Italy Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Norway Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 India Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Australia Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Pathology Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 List of key emerging company's/Allergen disruptors/innovators